Armistice Capital »

Neurosense Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $470k 662k 0.71
2023-06-30 $1.9M 1.3M 1.49

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Neurosense Therapeutics

Meitav Dash Investments
Hrt Financial
UBS Group
CWM

View all funds holding Neurosense Therapeutics